SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-171095
Filing Date
2021-05-24
Accepted
2021-05-24 17:22:20
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d560468d10q.htm 10-Q 242019
2 EX-2.1 d560468dex21.htm EX-2.1 19074
3 EX-10.1 d560468dex101.htm EX-10.1 102908
4 EX-31.1 d560468dex311.htm EX-31.1 11321
5 EX-31.2 d560468dex312.htm EX-31.2 11314
6 EX-32.1 d560468dex321.htm EX-32.1 3970
7 EX-32.2 d560468dex322.htm EX-32.2 3912
  Complete submission text file 0001193125-21-171095.txt   2653771

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT srngu-20210331.xml EX-101.INS 364807
9 XBRL TAXONOMY EXTENSION SCHEMA srngu-20210331.xsd EX-101.SCH 38165
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srngu-20210331_cal.xml EX-101.CAL 22802
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srngu-20210331_def.xml EX-101.DEF 190611
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE srngu-20210331_lab.xml EX-101.LAB 249879
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srngu-20210331_pre.xml EX-101.PRE 238391
Mailing Address 955 FIFTH AVENUE NEW YORK NY 10075
Business Address 955 FIFTH AVENUE NEW YORK NY 10075 (310) 209-7280
Soaring Eagle Acquisition Corp. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40097 | Film No.: 21956213
SIC: 2836 Biological Products, (No Diagnostic Substances)